AWM
TPI

Avior Wealth Management’s TIANYIN PHARMACEUTICAL TPI Stock Holding History

Avior Wealth Management’s Portfolio TPI Stock Details TPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,100
Closed – – 404
2015
Q1 		$0 Buy
+1,100
New +$624 ﹤0.01% 376

Other funds holding TPI

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAM
Pope Asset Management Memphis, Tennessee $162M AUM
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CHP
Cable Hill Partners Portland, Oregon $1.02B AUM 8.59% 1-Year Est. Return
RIM
Regent Investment Management Louisville, Kentucky $373M AUM 10.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Avior Wealth Management's TPI Position: Q2 2015 in Review

Avior Wealth Management sold out of TIANYIN PHARMACEUTICAL (TPI) in Q2 2015, closing a stake of 1,100 shares.

Avior Wealth Management first reported a position in TPI in Q1 2015 and held it in 1 quarter. The position peaked at $0 in Q1 2015. 7 funds tracked by Wall St. Rank hold TPI as of Q2 2015.

  • Avior Wealth Management reported no remaining TIANYIN PHARMACEUTICAL position as of Q2 2015 after selling out during the quarter.
  • Avior Wealth Management sold 1,100 TIANYIN PHARMACEUTICAL shares in Q2 2015.
  • Avior Wealth Management first reported a position in TIANYIN PHARMACEUTICAL in Q1 2015 and held it in 1 quarter.
  • Avior Wealth Management's TIANYIN PHARMACEUTICAL position peaked at $0 in Q1 2015.
  • 7 funds tracked by Wall St. Rank held TIANYIN PHARMACEUTICAL as of Q2 2015.

Based on Avior Wealth Management's 13F filing for Q2 2015, filed 21 Aug 2015.